
Natco Pharma Ltd
NSE:NATCOPHARM

Intrinsic Value
The intrinsic value of one
NATCOPHARM
stock under the Base Case scenario is
739.56
INR.
Compared to the current market price of 843.6 INR,
Natco Pharma Ltd
is
Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Natco Pharma Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Natco Pharma Ltd
Balance Sheet Decomposition
Natco Pharma Ltd
Current Assets | 50B |
Cash & Short-Term Investments | 24.6B |
Receivables | 14.5B |
Other Current Assets | 10.9B |
Non-Current Assets | 32.4B |
Long-Term Investments | 3.7B |
PP&E | 25.4B |
Intangibles | 2.4B |
Other Non-Current Assets | 995m |
Free Cash Flow Analysis
Natco Pharma Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Natco Pharma Ltd
Revenue
|
42.8B
INR
|
Cost of Revenue
|
-5.8B
INR
|
Gross Profit
|
36.9B
INR
|
Operating Expenses
|
-17.4B
INR
|
Operating Income
|
19.5B
INR
|
Other Expenses
|
-877m
INR
|
Net Income
|
18.7B
INR
|
NATCOPHARM Profitability Score
Profitability Due Diligence
Natco Pharma Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Score
Natco Pharma Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
NATCOPHARM Solvency Score
Solvency Due Diligence
Natco Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
Natco Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NATCOPHARM Price Targets Summary
Natco Pharma Ltd
According to Wall Street analysts, the average 1-year price target for
NATCOPHARM
is 1 123.36 INR
with a low forecast of 717.1 INR and a high forecast of 1 758.75 INR.
Dividends
Current shareholder yield for NATCOPHARM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NATCOPHARM
stock under the Base Case scenario is
739.56
INR.
Compared to the current market price of 843.6 INR,
Natco Pharma Ltd
is
Overvalued by 12%.